• Return to Headlines

Amphastar Pharma has the Lowest Projected Earnings Growth in the Pharmaceuticals Industry (AMPH, MRK, PRGO, LCI, PFE)

By James Quinn

Below are the three companies in the Pharmaceuticals industry with the lowest projected earnings growth. The growth of earnings per share (current fiscal year estimated vs. last year actual) is important to gauge future profitability and relative value. Higher EPS growth generally justifies higher earnings multiples.

Amphastar Pharma ranks lowest with a projected earnings growth of 1.3%. Following is Merck & Co with a projected earnings growth of 6.4%. Perrigo Co Plc ranks third lowest with a projected earnings growth of 6.9%.

Lannett Co Inc follows with a projected earnings growth of 9.8%, and Pfizer Inc rounds out the bottom five with a projected earnings growth of 11.2%.

SmarTrend recommended that subscribers consider buying shares of Perrigo Co Plc on January 31st, 2019 as our technology indicated a new Uptrend was in progress when shares hit $46.73. Since that recommendation, shares of Perrigo Co Plc have risen 6.4%. We continue to monitor Perrigo Co Plc for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: lowest projected earnings growth amphastar pharma Merck & Co perrigo co plc lannett co inc pfizer inc

Ticker(s): AMPH MRK PRGO LCI PFE